|
Quality Id |
Measure Name |
High Priority |
Measure Type |
Measure Description |
|
065 |
Appropriate
Treatment for Children with Upper Respiratory Infection (URI) |
No |
Process |
Percentage
of children 3 months-18 years of age who were diagnosed with upper
respiratory infection (URI) and were not dispensed an antibiotic prescription
on or three days after the episode |
|
066 |
Appropriate
Testing for Children with Pharyngitis |
No |
Process |
Percentage
of children 3-18 years of age who were diagnosed with pharyngitis,
ordered an antibiotic and received a group A streptococcus (strep) test for
the episode |
|
091 |
Acute
Otitis Externa (AOE):
Topical Therapy |
No |
Process |
Percentage
of patients aged 2 years and older with a diagnosis of AOE who were
prescribed topical preparations |
|
093 |
Acute
Otitis Externa (AOE):
Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use |
No |
Process |
Percentage
of patients aged 2 years and older with a diagnosis of AOE who were not
prescribed systemic antimicrobial therapy |
|
110 |
Preventive
Care and Screening: Influenza Immunization |
No |
Process |
Percentage
of patients aged 6 months and older seen for a visit between October 1 and
March 31 who received an influenza immunization OR who reported previous
receipt of an influenza immunization |
|
134 |
Preventive
Care and Screening: Screening for Depression and Follow-Up Plan |
No |
Process |
Percentage
of patients aged 12 years and older screened for depression on the date of
the encounter using an age appropriate standardized depression screening tool
AND if positive, a follow-up plan is documented on the date of the positive
screen |
|
205 |
HIV/AIDS:
Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis |
No |
Process |
Percentage
of patients aged 13 years and older with a diagnosis of HIV/AIDS for whom chlamydia, gonorrhea, and syphilis screenings were
performed at least once since the diagnosis of HIV infection |
|
391 |
Follow-Up
After Hospitalization for Mental Illness (FUH) |
Yes |
Process |
The
percentage of discharges for patients 6 years of age and older who were
hospitalized for treatment of selected mental illness diagnoses and who had a
follow-up visit with a mental health practitioner. Two rates are
submitted: |
|
394 |
Immunizations
for Adolescents |
No |
Process |
The
percentage of adolescents 13 years of age who had the recommended
immunizations by their 13th birthday |
|
398 |
Optimal
Asthma Control |
Yes |
Outcome |
Composite
measure of the percentage of pediatric and adult patients whose asthma is
well-controlled as demonstrated by one of three age appropriate patient
reported outcome tools and not at risk for exacerbation |
|
402 |
Tobacco
Use and Help with Quitting Among Adolescents |
No |
Process |
The
percentage of adolescents 12 to 20 years of age with a primary care visit
during the measurement year for whom tobacco use status was documented and
received help with quitting if identified as a tobacco user |
|
444 |
Medication
Management for People with Asthma |
Yes |
Process |
The
percentage of patients 5-64 years of age during the measurement year who were
identified as having persistent asthma and were dispensed appropriate
medications that they remained on for at least 75% of their treatment period |
|
447 |
Chlamydia
Screening and Follow Up |
No |
Process |
The
percentage of female adolescents 16 years of age who had a chlamydia screening test with proper follow-up during the
measurement period |
|
464 |
Otitis Media with Effusion (OME): Systemic
Antimicrobials- Avoidance of Inappropriate Use |
Yes |
Process |
Percentage
of patients aged 2 months through 12 years with a diagnosis of OME who were
not prescribed systemic antimicrobials |
|
467 |
Developmental
Screening in the First Three Years of Life |
No |
Process |
The
percentage of children screened for risk of developmental, behavioral and
social delays using a standardized screening tool in the 12 months preceding
or on their first, second, or third birthday. This is a composite measure of
screening in the first three years of life that includes three, age-specific
indicators assessing whether children are screened in the 12 months
proceeding or on their first, second or third birthday |